Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn

Table of Contents

January 01, 2003; Volume 31,Issue 1

Short Communications

  • You have access
    Expression and Cyclic Variability of CYP3A4 and CYP3A7 Isoforms in Human Endometrium and Cervix During the Menstrual Cycle
    Mohamadi A. Sarkar, Vijay Vadlamuri, Shobha Ghosh and Douglas D. Glover
    Drug Metabolism and Disposition January 2003, 31 (1) 1-6; DOI: https://doi.org/10.1124/dmd.31.1.1
  • You have access
    Constitutive Androstane Receptor and Pregnane X Receptor Gene Expression in Human Liver: Interindividual Variability and Correlation with CYP2B6 mRNA Levels
    Thomas K. H. Chang, Stelvio M. Bandiera and Jie Chen
    Drug Metabolism and Disposition January 2003, 31 (1) 7-10; DOI: https://doi.org/10.1124/dmd.31.1.7
  • You have access
    Bioflavonoid Stimulation of Glutathione Transport by the 190-kDa Multidrug Resistance Protein 1 (MRP1)
    Elaine M. Leslie, Roger G. Deeley and Susan P. C. Cole
    Drug Metabolism and Disposition January 2003, 31 (1) 11-15; DOI: https://doi.org/10.1124/dmd.31.1.11

Articles

  • You have access
    Cocaethylene Metabolism and Interaction with Cocaine and Ethanol: Role of Carboxylesterases
    S. Casey Laizure, Timothy Mandrell, Naomi M. Gades and Robert B. Parker
    Drug Metabolism and Disposition January 2003, 31 (1) 16-20; DOI: https://doi.org/10.1124/dmd.31.1.16
  • You have access
    Mouse Liver and Kidney Carboxylesterase (M-LK) Rapidly Hydrolyzes Antitumor Prodrug Irinotecan and the N-Terminal Three Quarter Sequence Determines Substrate Selectivity
    Mingxing Xie, Dongfang Yang, Micheal Wu, Bob Xue and Bingfang Yan
    Drug Metabolism and Disposition January 2003, 31 (1) 21-27; DOI: https://doi.org/10.1124/dmd.31.1.21
  • You have access
    Mechanism-Based Inactivation of Cytochrome P450 2B6 by a Novel Terminal Acetylene Inhibitor
    Peter W. Fan, Chungang Gu, Sandra A. Marsh and Jeffrey C. Stevens
    Drug Metabolism and Disposition January 2003, 31 (1) 28-36; DOI: https://doi.org/10.1124/dmd.31.1.28
  • You have access
    Acyl Glucuronidation and Glucosidation of a New and Selective Endothelin ETA Receptor Antagonist in Human Liver Microsomes
    Cuyue Tang, Jerome H. Hochman, Bennett Ma, Raju Subramanian and Kamlesh P. Vyas
    Drug Metabolism and Disposition January 2003, 31 (1) 37-45; DOI: https://doi.org/10.1124/dmd.31.1.37
  • You have access
    The Mechanism-Based Inactivation of Human Cytochrome P450 2B6 by Phencyclidine
    Monica I. Jushchyshyn, Ute M. Kent and Paul F. Hollenberg
    Drug Metabolism and Disposition January 2003, 31 (1) 46-52; DOI: https://doi.org/10.1124/dmd.31.1.46
  • You have access
    The Metabolism of Clopidogrel Is Catalyzed by Human Cytochrome P450 3A and Is Inhibited by Atorvastatin
    Thomas A. Clarke and Lucy A. Waskell
    Drug Metabolism and Disposition January 2003, 31 (1) 53-59; DOI: https://doi.org/10.1124/dmd.31.1.53
  • You have access
    Differences in Cytochrome P450 Forms Involved in the Metabolism ofN,N-Dipropyl-2-[4-methoxy-3-(2-phenylethoxy)phenyl]ethylamine monohydrochloride (NE-100), a Novel Sigma Ligand, in Human Liver and Intestine
    Takahito Yamamoto, Naoko Hagima, Masato Nakamura, Yoshiro Kohno, Kiyoshi Nagata and Yasushi Yamazoe
    Drug Metabolism and Disposition January 2003, 31 (1) 60-66; DOI: https://doi.org/10.1124/dmd.31.1.60
  • You have access
    Comparative Biotransformation of Radiolabeled [14C]Omapatrilat and Stable-labeled [13C2]Omapatrilat after Oral Administration to Rats, Dogs, and Humans
    Ramaswamy A. Iyer, Bimal Malhotra, Sanaullah Khan, James Mitroka, Samuel Bonacorsi, Stephen C. Waller, J. Kent Rinehart and Kishin Kripalani
    Drug Metabolism and Disposition January 2003, 31 (1) 67-75; DOI: https://doi.org/10.1124/dmd.31.1.67
  • You have access
    Metabolism, Pharmacokinetics, and Excretion of a Highly SelectiveN-Methyl-d-aspartate Receptor Antagonist, Traxoprodil, in Human Cytochrome P450 2D6 Extensive and Poor Metabolizers
    Kim Johnson, Ajit Shah, Sarah Jaw-Tsai, James Baxter and Chandra Prakash
    Drug Metabolism and Disposition January 2003, 31 (1) 76-87; DOI: https://doi.org/10.1124/dmd.31.1.76
  • You have access
    Disposition and Metabolic Fate of Atomoxetine Hydrochloride: Pharmacokinetics, Metabolism, and Excretion in the Fischer 344 Rat and Beagle Dog
    Edward L. Mattiuz, G. Douglas Ponsler, Robert J. Barbuch, Paul G. Wood, John H. Mullen, Richard L. Shugert, Qimin Li, William J. Wheeler, Fengjiun Kuo, Preston C. Conrad and John-Michael Sauer
    Drug Metabolism and Disposition January 2003, 31 (1) 88-97; DOI: https://doi.org/10.1124/dmd.31.1.88
  • You have access
    Disposition and Metabolic Fate of Atomoxetine Hydrochloride: The Role of CYP2D6 in Human Disposition and Metabolism
    John-Michael Sauer, G. Douglas Ponsler, Edward L. Mattiuz, Amanda J. Long, Jennifer W. Witcher, Holly R. Thomasson and Karl A. Desante
    Drug Metabolism and Disposition January 2003, 31 (1) 98-107; DOI: https://doi.org/10.1124/dmd.31.1.98
  • You have access
    Glucuronidation of 7-Ethyl-10-hydroxycamptothecin (SN-38), an Active Metabolite of Irinotecan (CPT-11), by Human UGT1A1 Variants, G71R, P229Q, and Y486D
    Hideto Jinno, Toshiko Tanaka-Kagawa, Nobumitsu Hanioka, Mayumi Saeki, Seiichi Ishida, Tetsuji Nishimura, Masanori Ando, Yoshiro Saito, Shogo Ozawa and Jun-ichi Sawada
    Drug Metabolism and Disposition January 2003, 31 (1) 108-113; DOI: https://doi.org/10.1124/dmd.31.1.108
  • You have access
    Amino Acid Conjugates: Metabolites of 2-Propylpentanoic Acid (Valproic Acid) in Epileptic Patients
    V. S. Gopaul, W. Tang, K. Farrell and F. S. Abbott
    Drug Metabolism and Disposition January 2003, 31 (1) 114-121; DOI: https://doi.org/10.1124/dmd.31.1.114
  • You have access
    Metabolism of (S)-5,6-Difluoro-4-cyclopropylethynyl-4-trifluoromethyl-3, 4-dihydro-2(1H)-quinazolinone, a Non-Nucleoside Reverse Transcriptase Inhibitor, in Human Liver Microsomes. Metabolic Activation and Enzyme Kinetics
    Hao Chen, Weiqi Chen, Liang-Shang Gan and Abdul E. Mutlib
    Drug Metabolism and Disposition January 2003, 31 (1) 122-132; DOI: https://doi.org/10.1124/dmd.31.1.122
  • You have access
    Validation of Serotonin (5-Hydroxtryptamine) as an in Vitro Substrate Probe for Human UDP-Glucuronosyltransferase (UGT) 1A6
    Soundararajan Krishnaswamy, Su X. Duan, Lisa L. von Moltke, David J. Greenblatt and Michael H. Court
    Drug Metabolism and Disposition January 2003, 31 (1) 133-139; DOI: https://doi.org/10.1124/dmd.31.1.133
  • You have access
    Bisphenol A Glucuronidation and Absorption in Rat Intestine
    Hiroki Inoue, Go Yuki, Hiroshi Yokota and Seiyu Kato
    Drug Metabolism and Disposition January 2003, 31 (1) 140-144; DOI: https://doi.org/10.1124/dmd.31.1.140

Letter to the Editor

  • You have access
    Evaluation of Recombinant Cytochromes P450 Activity in Metabolic Pathways
    Bertrand Rochat
    Drug Metabolism and Disposition January 2003, 31 (1) 145-146; DOI: https://doi.org/10.1124/dmd.31.1.145
Back to top
PreviousNext

In this issue

Drug Metabolism and Disposition: 31 (1)
Drug Metabolism and Disposition
Vol. 31, Issue 1
1 Jan 2003
  • Table of Contents
  • About the Cover
  • Index by author
Sign up for alerts

Jump to

  • Short Communications
  • Articles
  • Letter to the Editor
  • Most Read
Loading
  • PBPK Modeling for Clopidogrel and Its Active Metabolite
  • Physiology of the Neonatal Gastrointestinal System
  • Pharmacokinetics and Disposition of Biologics
  • Tissue Drug Concentrations: Beyond the Free Drug Hypothesis
  • Metabolism and Disposition of Volanesorsen across Species
More...
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics